Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

Broutier, Laura, Mastrogiovanni, Gianmarco, Verstegen, Monique MA, Francies, Hayley E, Gavarró, Lena Morrill, Bradshaw, Charles R, Allen, George E, Arnes-Benito, Robert +14 more·2017·Nature Medicine

Cited by (1,001)

Items 801–900 of 1,001

  1. A critical review of additive manufacturing technology in rehabilitation medicine via the use of visual knowledge graph
    Weihua Lu, Wenxin He, Jiaming Wu, Yicha Zhang · 2022 · Virtual and Physical Prototyping
  2. Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection
    Katherine Anne Johnson, Rebecca A. DeStefanis, Philip B. Emmerich, Patrick Thomas Grogan, Jeremy D. Kratz, Sarbjeet K. Makkar, Linda J. Clipson, Dustin A. Deming · 2020 · Current Treatment Options in Oncology
  3. Engineering Biomimetic Microenvironment for Organoid
    Chen, Shuo, Wang, Lijuan, Yang, Lei, Rana, Abdus Samad, He, Chuanglong · 2023 · Macromolecular Bioscience
  4. Mini-organs with big impact: Organoids in liver cancer studies
    Muhammad Babar Khawar, YAJUN WANG, ANEEQA MAJEED, ALI AFZAL, Kabeer Haneef, Haibo Sun · 2023 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  5. Cancer 3D Models for Metallodrug Preclinical Testing
    Diogo M. Engrácia, Catarina I. G. Pinto, Filipa Mendes · 2023 · International Journal of Molecular Sciences
  6. Inhibition of the transmembrane transporter ABCB1 overcomes resistance to doxorubicin in patient-derived organoid models of HCC
    Lauriane Blukacz, Sandro Nuciforo, Geoffrey Fucile, Fredrik Trulsson, Urs Duthaler, Stefan F. Wieland, Markus Hermann Heim · 2024 · Hepatology Communications
  7. Application and prospect of organoid technology in breast cancer
    Shanlin Huang, Zifan Mei, Andi Wan, Min Zhao, Xiaowei Qi · 2024 · Frontiers in Immunology
  8. Recent advances in bioactivity-guided drug screening strategies for pre-clinical and clinical drug discovery
    Simin Chen, Chenxiao Shen, Wanyu Li, Yu Fan, Dong‐Hua Yang, Yitao Wang, Ruibing Feng, Guodong Li, Zhangfeng Zhong · 2024 · TrAC Trends in Analytical Chemistry
  9. Advances, challenges and future applications of liver organoids in experimental regenerative medicine
    Da Gong, Jiaye Mo, Mei Zhai, Fulin Zhou, Guo‐Cai Wang, Shaohua Ma, Xiaoyong Dai, Xuesong Deng · 2025 · Frontiers in Medicine
  10. Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity
    Jeremy D. Kratz, Shujah Rehman, Katherine Anne Johnson, Amani A. Gillette, Aishwarya Sunil, Peter F. Favreau, Cheri A. Pasch, Devon D. Miller, Lucas C. Zarling, Austin H. Yeung et al. · 2025 · Scientific Reports
  11. Applications and challenges of patient-derived organoids in hepatobiliary and pancreatic cancers
    Jia-Wei Hu, Yanzhi Pan, Xiaoxiao Zhang, Jiangtao Li, Yun Jin · 2025 · World Journal of Gastroenterology
  12. The optimization of combinatorial drug therapies: Strategies and laboratorial platforms
    Boqian Wang, Antony R. Warden, Xianting Ding · 2021 · Drug Discovery Today
  13. Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends
    Shenglei Song, Bo Li, Mariana R. Carvalho, Huijun Wang, Deli Mao, Jitao Wei, Wei Chen, Zhi-Hui Weng, Yangchao Chen, Chu‐Xia Deng et al. · 2022 · Pharmacology & Therapeutics
  14. Organoids: approaches and utility in cancer research
    Bing‐Rui Zhou, Zhiwei Feng, Jun Xu, Jun Xie · 2023 · Chinese Medical Journal
  15. Effective Treatment for Recurrent Ovarian Cancer Guided by Drug Sensitivity from Ascites-Derived Organoid: A Case Report
    Wanyi Chen, Po-Han Fang, Bin Zheng, Yue Liang, Yiwen Mao, Xuefeng Jiang, Qiong-Lan Tang · 2023 · International Journal of Women s Health
  16. Liver organoids and their application in liver cancer research
    Xinyu Song, Kaifei Hou, Hongyan Zhou, Jingyi Yang, Ting Cao, Jiayu Zhang · 2023 · Regenerative Therapy
  17. Naturally Occurring and Engineered Alphaviruses Sensitive to Double-Stranded-RNA-Activated Protein Kinase Show Restricted Translation in Mammalian Cells, Increased Sensitivity to Interferon, and Marked Oncotropism
    René Toribio, Irene Díaz‐López, Juan José Berlanga, Francisca Molina‐Jiménez, Pedro Lorenzo Majano, Iván Ventoso · 2019 · Journal of Virology
  18. Novel patient-derived 3D culture models to guide clinical decision-making in prostate cancer
    Annelies Van Hemelryk, Wytske M. van Weerden · 2020 · Current Opinion in Endocrine and Metabolic Research
  19. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line
    Dae Hee Pyo, Hye Kyung Hong, Woo Yong Lee, Yong Beom Cho · 2020 · Cancer Biology & Therapy
  20. Organoids in Tissue Transplantation
    Derya Sağraç, Hatice Burcu Şişli, Selinay Şenkal, Taha Bartu Hayal, Fikrettin Şahin, Ayşegül Doğan · 2021 · Advances in experimental medicine and biology
  21. Next-Generation Modeling of Cancer Using Organoids
    Jillian R Love, Wouter R. Karthaus · 2023 · Cold Spring Harbor Perspectives in Medicine
  22. Double-negative T cells: a promising avenue of adoptive cell therapy in transplant oncology
    Zhihang Hu, Modan Yang, Hao Chen, Chiyu He, Zuyuan Lin, Xinyu Yang, Huigang Li, Wei Shen, Di Lu, Xiao Xu · 2023 · Journal of Zhejiang University SCIENCE B
  23. Establishment of bladder cancer spheroids and cultured in microfluidic platform for predicting drug response
    Qiao Xiong, Ting Liu, Yidie Ying, Xiaowen Yu, Ziwei Wang, Hongliang Gao, Tianhai Lin, Weihua Fan, Zhensheng Zhang, Qiang Wei et al. · 2023 · Bioengineering & Translational Medicine
  24. Imaging‐Based Efficacy Evaluation of Cancer Immunotherapy in Engineered Tumor Platforms and Tumor Organoids
    Seong‐Eun Kim, Suji Yun, Junsang Doh, Hong Nam Kim · 2024 · Advanced Healthcare Materials
  25. Recent advances in biomimetic taste-based biosensors and their applications
    Jialu Kang, Jiejing Liu, Yufei Geng, Yuxuan Yuan, Shuge Liu, Yushuo Tan, Liping Du, Chunsheng Wu · 2024 · Sensors & Diagnostics
  26. Mesenchymal stromal cells promote the formation of lung cancer organoids via Kindlin-2
    Zhilin Sui, Xianxian Wu, Jiaxin Wang, ShihJye Tan, Chao Zhao, Zhentao Yu, Chuanyue Wu, Xiaoxiao Wang, Ling Guo · 2025 · Stem Cell Research & Therapy
  27. Patient-Derived Tumor Organoids: A Platform for Precision Therapy of Colorectal Cancer
    Yiran Li, Wei Wu, Jiaxin Yao, Suidong Wang, Xiufeng Wu, Jun Yan · 2025 · Cell Transplantation
  28. Organoids in Dynamic Culture: Microfluidics and 3D Printing Technologies
    Xin Su, Mingqi Wang, Ruqiang Yuan, Lina Guo, Yinhe Han, Chun Huang, Ang Li, David Lee Kaplan, Xiuli Wang · 2025 · ACS Biomaterials Science & Engineering
  29. NEK7-induced phosphorylation of EGFR on serine 1070 drives the acquired lenvatinib resistance in hepatocellular carcinoma
    Qibo Huang, Weijian Wang, Qianyun Ge, Dafeng Xu, Renshun Dong, Ruizhi Chang, Xing Wu, Jie Mo, Su Chen, Ning Deng et al. · 2025 · Hepatology
  30. Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents
    Mohamed E. Ali, Hamada Mohamed Halby, Mamdouh Yones Ali, Elham Ahmed Hassan, Mohamed A. El‐Mokhtar, Ibrahim M. Sayed, Marwa M. Thabet, Magdy Fouad, Ahmed M. El-Ashmawy, Zainab Gaber Mahran · 2021 · Viruses
  31. Current status of organoid culture in urological malignancy
    Ryan Tsz‐Hei Tse, Hongda Zhao, Christine Yim‐Ping Wong, Peter Ka‐Fung Chiu, Jeremy Yuen‐Chun Teoh, Chi‐Fai Ng · 2021 · International Journal of Urology
  32. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy
    Lucia Cerrito, Maria Elena Ainora, Carolina Mosoni, Raffaele Borriello, Antonio Gasbarrini, Maria Assunta Zocco · 2022 · Cancers
  33. Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
    Weisong Xue, Ting Wang, Jiaxin Yao, Wei Wu, Dexin Chen, Botao Yan, Xiaoyu Dong, Yuting Tang, Yunli Zeng, Yueyu He et al. · 2023 · Bioengineering & Translational Medicine
  34. Colorectal cancer tissue-originated spheroids reveal tumor intrinsic signaling pathways and mimic patient clinical chemotherapeutic response as a rapid and valid model
    Yuchen Zhang, Jianting Huo, Suyue Yu, Wenqing Feng, Abudumaimaitijiang Tuersun, Fangqian Chen, Zeping Lv, Wangyi Liu, Jingkun Zhao, Zhuoqing Xu et al. · 2023 · Biomedicine & Pharmacotherapy
  35. Complexity in in-vitro tumor microenvironment reconstruction for drug screening and personalized medicine
    Amit Kumar Ghosh, Soham Ghosh, Falguni Pati, Suhanya Duraiswamy · 2023 · Bioprinting
  36. Advances towards the use of gastrointestinal tumor patient-derived organoids as a therapeutic decision-making tool
    Javiera Obreque, Luis Vergara-Gómez, Nicolás Venegas, Helga L. Weber, Gareth I. Owen, Pablo Ernesto Pérez, Pamela Leal, Juan Carlos Roa, Carolina Bizama · 2023 · Biological Research
  37. Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma
    Renshun Dong, Tianci Wang, Wei Dong, He Zhu, Qiumeng Liu, Huifang Liang, Xiaoping Chen, Bixiang Zhang, Xuewu Zhang · 2024 · Biomedicine & Pharmacotherapy
  38. Lymphotoxin beta‐activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma
    Kaiyu Xu, Annika Kessler, Federico Nichetti, Paula Hoffmeister‐Wittmann, Anna‐Lena Scherr, Luisa Nader, Eblina Kelmendi, Nathalie Schmitt, Maximilian Schwab, Maria Garcia Beccaria et al. · 2024 · Liver International
  39. Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
    Liangtao Ye, Lydia Kriegl, Florian Paul Reiter, Stefan Munker, Timo Itzel, Andreas Teufel, Andreas Ziesch, Helga‐Paula Török, Thomas Kirchner, Alexander L. Gerbes et al. · 2020 · Clinical and Translational Gastroenterology
  40. From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease
    Roni F. Kunst, Marije Niemeijer, Luc J. W. van der Laan, Bart Spee, Stan F.J. van de Graaf · 2020 · Biochemical Pharmacology
  41. Systemic treatment of penile squamous cell carcinoma—hurdles and hopes of preclinical models and clinical regimens: a narrative review
    Anita Thomas, Luísa Matos do Canto, Cláudia Aparecida Rainho, Eva Juengel, Roman Alexander Blaheta, Philippe E. Spiess, Sílvia Regina Rogatto, Igor Tsaur · 2021 · Translational Andrology and Urology
  42. Tissue Engineering Modalities and Nanotechnology
    Hoda A. Elkhenany, M. Abd Elkodous, Steven D. Newby, Azza M. El-Derby, Madhu S Dhar, Nagwa El‐Badri · 2020 · Learning materials in biosciences
  43. In vitro 3D liver tumor microenvironment models for immune cell therapy optimization
    Maxine S. Y. Lam, Jose Antonio Reales‐Calderón, Jin Rong Ow, Giulia Adriani, Andrea Pavesi · 2021 · APL Bioengineering
  44. Preparation and application of taste bud organoids in biomedicine towards chemical sensation mechanisms
    Shuge Liu, Ping Zhu, Yulan Tian, Yating Chen, Yage Liu, Wei Chen, Liping Du, Chunsheng Wu · 2022 · Biotechnology and Bioengineering
  45. Evaluation of the tumoricidal efficacy of adoptive cell transfer using hepatocellular carcinoma-derived organoids
    Zizhen Zhou, Xiaoluan Yan, Wanwan Shi, Kangan Tan, Chen Shao, Yan Wang, Guiqiang Wang, Yuan Hong · 2022 · Journal of Gastrointestinal Oncology
  46. Well-free agglomeration and on-demand three-dimensional cell cluster formation using guided surface acoustic waves through a couplant layer
    Jiyang Mei, Aditya Vasan, Uri Magaram, Kenjiro Takemura, Sreekanth H. Chalasani, James Robert Friend · 2022 · Biomedical Microdevices
  47. Combination strategies to target metabolic flexibility in cancer
    Jelena Krstić, Katharina Schindlmaier, Andreas Prokesch · 2022 · International review of cytology
  48. Organoids from Patient Biopsy Samples can Predict the Response of BC Patients to Neoadjuvant Chemotherapy
    Dan Shu, Meiying Shen, Kang Li, Xiaojian Han, Li Han, Zhaofu Tan, Yu Wang, Yang Peng, Zhenrong Tang, Chi Qu et al. · 2021 · Research Square
  49. HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids
    Di-Wei Tang, I‐Chung Chen, Po-Yu Chou, Mei-Jung Lai, Zheng-Yang Liu, Kelvin K. Tsai, Li‐Hsin Cheng, Jian-Xun Zhao, Er-Chieh Cho, Hung-Hsuan Chang et al. · 2024 · European Journal of Medicinal Chemistry
  50. Spatially defined microenvironment for engineering organoids
    Yilan Zhang, Fukang Qi, Peng Chen, Bi‐Feng Liu, Yiwei Li · 2024 · Biophysics Reviews
  51. Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure
    Rui Wang, Youwei Chen, Jiazhen Han, Huikang Ye, Huiran Yang, Qianyan Li, Yizhen He, Boyu Ma, Junjie Zhang, Yanli Ge et al. · 2024 · Nature Communications
  52. Remodeling and repair of the damaged brain: the potential and challenges of organoids for ischaemic stroke
    Yi-Xuan Hao, Chenrui Li, Zhijie Lu, Nan Kong, Rong-Hua Huang, Shuyan Ma, Wen-Fei Zhou, Hao Jiao, Yue Qiu, Yuan-Feng Yu et al. · 2025 · Journal of Translational Medicine
  53. Advances in Biliary Disease Organoid Research: From Model Construction to Clinical Applications
    Boming Peng, Min Huang, Jianquan Zhang, Yang Xiang · 2025 · Advanced Healthcare Materials
  54. Physiopathological Features in a Three-Dimensional In Vitro Model of Hepatocellular Carcinoma: Hypoxia-Driven Oxidative Stress and ECM Remodeling
    Maria Giovanna Rizzo, Enza Fazio, Claudia De Pasquale, Emanuele Luigi Sciuto, Giorgia Cannatà, Cristiana Roberta Multisanti, Federica Impellitteri, Federica Gilda D’Agostino, Salvatore P. P. Guglielmino, Caterina Faggio et al. · 2025 · Cancers
  55. Elemene Augments the Effects of Anti‐PD‐1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR‐130a‐5p/SPP/MHC‐I Axis
    Menglan Wang, Mengqing Sun, Heng Dong, Xiaoting Zhang, Jingbo Zhang, Zhengguo Zhang, Mengjie Ni, Lina Li, Yunxin Pei, X Chen et al. · 2026 · Advanced Science
  56. Micro Pattern‐Based 3D Cell Culture Platform: An Overview of Technologies and Applications
    Xinglong Zhu, Yi Li, Hulin Long, Yijia Wu, Ningwei Sun, Shun Li, Yiyao Liu, Huiqi Xie, Ji Bao · 2026 · Exploration
  57. Novel gold nanoparticles targeting somatostatin receptor subtype two with near-infrared light for neuroendocrine tumour therapy
    Qichen Chen, Zilin Li, Jiangyuan Yu, Qing Xie, Haizhen Lu, Yiqiao Deng, Jinghua Chen, Wenjia Zhu, Li Huo, Yizhou Zhang et al. · 2022 · Nano Research
  58. Protocols to culture and harvest hepatic tumor organoids for metabolic assays
    Man Tong, Stephanie Ma · 2022 · STAR Protocols
  59. Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
    Sofi Sennefelt Nyman, Håkan K. Ahlström, Angeliki Dimopoulou, David Dahlgren, Mikael Hedeland, Femke Heindryckx, Ulf Johnson, Jaafar Khaled, Fredrik Kullenberg, Rickard S. Nyman et al. · 2022 · BMJ Open
  60. A narrative review of organoids for investigating organ aging: opportunities and challenges
    Xiaoyan Sun, Fei Sun, Yixin Zhang, Jing Tao Qu, Weiqi Zhang, Guanghui Liu · 2023 · Journal of Bio-X Research
  61. Discovery platforms for RNA therapeutics
    Giulio Ciucci, Luca Braga, Serena Zacchigna · 2024 · British Journal of Pharmacology
  62. Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma
    Fan Zou, Jialiang Wei, Jialang Zhuang, Yafang Liu, Jizhou Tan, Xianzhang Huang, Ting Liu · 2024 · Frontiers of Medicine
  63. Primary liver cancer organoids and their application to research and therapy
    Xiaobin Zhu, Rajiv Trehan, Changqing Xie · 2024 · Journal of the National Cancer Center
  64. Screening-Based Chemical Approaches to Unravel Stem Cell Biology
    Shuibing Chen · 2018 · Stem Cell Reports
  65. Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases
    Ken Liu, Jinbiao Chen, Geoffrey William McCaughan · 2020 · Hepatoma Research
  66. COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management
    Chenyang Ye, Lina Qi, Wang Ji, Shu Sen Zheng · 2021 · Frontiers in Medicine
  67. Advance in Human Epithelial-Derived Organoids Research
    Fengjiao Li, Peng Zhang, Saizhi Wu, Lianwen Yuan, Zhonghua Liu · 2021 · Molecular Pharmaceutics
  68. Development and Application of Patient-Derived Cancer Organoidsin Clinical Management of Gastrointestinal Cancer: A State-of-the-Art Review
    Ruobing Zhang, Tiantian Guo, Lulin Ji, Yirui Yin, Shuitu Feng, Weihong Lu, Fei Zhang, Maoshu Zhu, Shugang Liu, Jinhua Jiang et al. · 2021 · Frontiers in Oncology
  69. Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients
    Lifeng Chen, Bo Tian, Wen Liu, Hai‐tao Liang, Yong You, Weizhen Liu · 2022 · Frontiers in Oncology
  70. 3D Culture of Primary Patient-Derived Hepatoblastoma Tumoroids
    Peng V. Wu, Roeland Nusse · 2022 · Methods in molecular biology
  71. Strategic use of organoids and organs-on-chip as biomimetic tools
    Anderson Kenedy Santos, Sérgio Scalzo, Raysa T. V. Souza, Pedro H. G. Santana, Bruno Lemes Marques, Lucas Felipe de Oliveira, Daniel Mendes Filho, Alexandre Hiroaki Kihara, Helton C. Santiago, Ricardo Cambraia Parreira et al. · 2022 · Seminars in Cell and Developmental Biology
  72. Organoids for Modeling (Colorectal) Cancer in a Dish
    Florian Rathje, Stefan Klingler, Fritz Aberger · 2022 · Cancers
  73. WITHDRAWN: In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models
    Sang‐Yun Lee, In-Seong Koo, Hyun Ju Hwang, Dong Woo Lee · 2023 · SLAS DISCOVERY · Retracted
  74. Innovative 3D microfluidic intestinal organoid model for assessing cadmium bioavailability in food: implications for enhanced exposure risk assessment
    Yan Li, Wen Jing Sun, Qiao Wang, Wan Shi, Yu Chen, Zhiyong Gong, Xiao Guo, Xin Liu, Yongning Wu · 2024 · Food Science and Human Wellness
  75. Organoid models of breast cancer in precision medicine and translational research
    Vahid Niazi, Benyamin Parseh · 2024 · Molecular Biology Reports
  76. The pros and cons of mechanical dissociation and enzymatic digestion in patient-derived organoid cultures for solid tumor
    Jing Ren, Mengli Liu, Mingjie Rong, Xuan Zhang, Gang Wang, Yihan Liu, Haijun Li, Shichao Duan · 2024 · Cell organoid (Print)
  77. Hepatobiliary organoid research: the progress and applications
    Rui-Qi Zou, Yu-Shi Dai, Fei Liu, Siqi Yang, Hai‐Jie Hu, Fu‐Yu Li · 2025 · Frontiers in Pharmacology
  78. Leveraging Multimodal Foundation Models in Biliary Tract Cancer Research
    Yashbir Singh, Jesper Bøje Andersen, Quincy Alexander Hathaway, Diana V. Vera-Garcia, Varekan Keishing, Sudhakar Kundapur Venkatesh, Sara Salehi, Davide Povero, Michael B. Wallace, Gregory James Gores et al. · 2025 · Tomography
  79. Organoid models established from primary tumors and patient-derived xenograft tumors reflect platinum sensitivity of ovarian cancer patients
    Parisa Nikeghbal, Dorsa Zamanian, Danielle Burke, Mara P. Steinkamp · 2025 · BMC Cancer
  80. High-throughput 3D engineered paediatric tumour models for precision medicine
    MoonSun Jung, Valentina Poltavets, Joanna N. Skhinas, Gábor Tax, Alvin Kamili, Jinhan Xie, Sarah Ghamrawi, Philipp Graber, Jie Mao, Marie Wong et al. · 2025 · Molecular Systems Biology
  81. Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma
    Fei Song, Yi-Jun Lu, Han Sun, Jian-Wen Cheng, Wenhua Li, Zhenhao Liu, Rui‐Zhe Li, Peng-Xiang Wang, Wen-Jing Zheng, Yu-Chen Zhong et al. · 2026 · Journal for ImmunoTherapy of Cancer
  82. Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer
    Alena Mičková, Martin Morong, Monika Levková, Daniela Kurfürstová, Gvantsa Kharaishvili, Ivo Überall, Vladimír Študent, Stanislav Drápela, Karel Souček, Jan Bouchal · 2022 · Klinicka onkologie
  83. Distinct roles of ADIPOR1 and ADIPOR2: A pan-cancer analysis
    Zhuoyuang Chen, Huiqin Yang, Yun-Feng Ren, Ze Yang, Jia-Zhen Huang, Cheng Li, Ying Xiong, Bin Yu · 2023 · Frontiers in Endocrinology
  84. Decellularized diseased tissues: current state‐of‐the‐art and future directions
    Xiang Li, Jianyang Shan, Xin Chen, Haomin Cui, Gen Wen, Yaling Yu · 2023 · MedComm
  85. Artificial tumor matrices and bioengineered tools for tumoroid generation
    Yung‐Chiang Liu, Ping Chen, Ray Chang, Xingjian Liu, Jhe-Wei Jhang, Myagmartsend Enkhbat, Shan Chen, Hongxia Wang, Chu‐Xia Deng, Peng‐Yuan Wang · 2024 · Biofabrication
  86. Beyond skin deep: Revealing the essence of iPS cell-generated skin organoids in regeneration
    Yu-Xuan Zhang, Yuan Zhou, Yuyun Xiong, Yumei Li · 2024 · Burns
  87. Liver and bile duct organoids and tumoroids
    Xuanming Luo, Yuda Gong, Zijun Gong, Kun Fan, Tao Suo, Han Liu, Xiaoling Ni, Xiaoling Ni, Miyesaier Abudureyimu, Houbao Liu · 2024 · Biomedicine & Pharmacotherapy
  88. The importance of preclinical models for cholangiocarcinoma drug discovery
    Felix J. Krendl, Florian Primavesi, Rupert Oberhuber, Daniel Neureiter, Matthias Ocker, Dino Bekric, Tobias Kiesslich, Christian Mayr · 2025 · Expert Opinion on Drug Discovery
  89. Bladder organoids: a step towards personalised cancer therapy?
    Sreemoti Banerjee, Jennifer Southgate · 2019 · Translational Andrology and Urology
  90. A Primary Cell and Organoid Platform for Evaluating Pharmacological Responses in Mammary Epithelial Cells
    Teneale A. Stewart, Felicity M. Davis · 2020 · ACS Pharmacology & Translational Science
  91. Application of positive behavior management in patients after breast cancer surgery
    Ying-Jie Hao, Huibo Sun, Hongwei Li, Bing-Jie Chen, Xiuli Chen, Lin Ma, Yingli Li · 2020 · World Journal of Clinical Cases
  92. 3D Organoid modelling of hepatoblast-like and mesenchymal-like hepatocellular carcinoma cell lines
    Özden Öz, Evin İşcan, Tuğçe Batur, Mehmet Öztürk · 2021 · Hepatoma Research
  93. Role of Biobanks for Cancer Research and Precision Medicine in Hepatocellular Carcinoma
    Peyda Korhan, Sanem Tercan Avcı, Yeliz Yılmaz, Yasemin Öztemur Islakoğlu, Neşe Atabey · 2021 · Journal of Gastrointestinal Cancer
  94. Immune index: A gene and cell prognostic signature for immunotherapy response prediction in hepatocellular carcinoma
    Xiuliang Cui, Lu Han, Longjiu Cui, Gongbo Fu, Erdong Liu, Duowei Wang, Bin Song, Yongxiang Zhang, Wenxia Zhou, Hongyang Wang et al. · 2022 · Pharmacological Research
  95. Updates on Organoid Model for the Study of Liver Cancer
    Korri Elvanita El-Khobar, Caecilia Hapsari Ceriapuri Sukowati · 2023 · Technology in Cancer Research & Treatment
  96. Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma
    Irina L. Sinenko, Fabien Kuttler, Valentin B. Simeonov, Alexandre Moulin, Patrick Aouad, Christina Stathopoulos, Francis L. Munier, Adeline Berger, Paul J. Dyson · 2023 · Cancer Science
  97. Progress and limitations in engineering cellular adhesion for research and therapeutics
    George Chao, Stefan A Zukin, Patrick R.J. Fortuna, Benjamin Boettner, George McDonald Church · 2023 · Trends in Cell Biology
  98. Testing in vitro toxicity of nanoparticles in 3D cell culture with various extracellular matrix scaffold
    Jae Won Choi, Song-Hwa Bae, In Young Kim, Minjeong Kwak, Tae Geol Lee, Min Beom Heo · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity
    Jeremy D. Kratz, Shujah Rehman, Katherine Anne Johnson, Amani A. Gillette, Aishwarya Sunil, Peter F. Favreau, Cheri A. Pasch, Devon D. Miller, Lucas C. Zarling, Austin H. Yeung et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Recent advances in lung cancer organoid (tumoroid) research (Review)
    Qiang Zhang, Mingyang Zhang · 2024 · Experimental and Therapeutic Medicine